Problem drinking and low-dose naltrexone-assisted opioid detoxification

Journal of Studies on Alcohol and Drugs

Volumn 72, Issue 3, 2011, Pages 507-513

  Mannelli, Paolo ^a   Peindl, Kathleen ^a   Patkar, Ashwin A ^a   Wu, Li Tzy ^a   Tharwani, Haresh M ^a   Gorelick, David A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79955626736     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2011.72.507     Document Type: Article

References (42)

1. Appel, P. W., Joseph, H., & Richman, B. L. (2000). Causes and rates of death among methadone maintenance patients before and after the onset of the HIV/AIDS epidemic. Mount Sinai Journal of Medicine, 67, 444-451.
2. Assadi, S. M., Radgoodarzi, R., & A hmadi-Abhari, S. A. (2003). Baclofen for maintenance treatment of opioid dependence: A randomized doubleblind placebo-controlled clinical trial [ISRCTN32121581]. BMC Psychiatry, 3.
3. Babor, T. F., Steinberg, K., Anton, R., & Del Boca, F. (2000). Talk is cheap: Measuring drinking outcomes in clinical trials. Journal of Studies on Alcohol, 61, 55-63.
4. Backmund, M., Schütz, C. G., Meyer, K., Eichenlaub, D., & Soyka, M. (2003). Alcohol consumption in heroin users, methadone-substituted and codeine-substituted patients-frequency and correlates of use. European Addiction Research, 9, 45-50.
5. Bickel, W. K., Marion, I., & Lowinson, J. H. (1987). The treatment of alcoholic methadone patients: A review. Journal of Substance Abuse Treatment, 4, 15-19.
6. Collins, E. D., Kleber, H. D., Whittington, R. A., & Heitler, N. E. (2005). Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxifi cation and naltrexone induction: A randomized trial. Journal of the American Medical Association, 294, 903-913.
7. Dervaux, A. (2005). Alcohol dependence and depressive disorders in the course of opiate dependence. Encephale, Pt. 2, S45-46.
8. el-Bassel, N., Schilling, R. F., Turnbull, J. E., & Su, K.-H. (1993). Correlates of alcohol use among methadone patients. Alcoholism, Clinical and Experimental Research, 17, 681-686.
9. Enoch, M. A., & Goldman, D. (2002). Problem drinking and alcoholism: diagnosis and treatment. American Family Physician, 65, 441-448
10. First, M. B., Spitzer, R. L., Miriam, G., & Williams, J. B. W. (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P). New York State Psychiatric Institute, New York, NY: Biometrics Research.
11. Handelsman, L., Cochrane, K. J., Aronson, M. J., Ness, R., Rubinstein, K. J., & Kanof, P. D. (1987). Two new rating scales for opiate withdrawal. American Journal of Drug and Alcohol Abuse, 13, 293-308.
12. Ji, D., Gilpin, N. W., Richardson, H. N., Rivier, C. L., & Koob, G. F. (2008). Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats. Behavioural Pharmacology, 19, 1-12.
13. Kampman, K., Gromov, I., Sirota, A., Silverman, B., Qiao, X., & Gastfriend, D. R. (May, 2008). Long-term safety and tolerability of extended-release naltrexone in alcohol- and/or opioid-dependent patients: A randomized, active-controlled study. Paper presented at the American Psychiatric Association Annual Conference, Washington, DC.
14. Kanof, P. D., Handelsman, L., Aronson, M. J., Ness, R., Cochrane, K. J., & Rubinstein, K. J. (1992). Clinical characteristics of naloxone precipitated withdrawal in human opioid-dependent subjects. Journal of Pharmacology and Experimental Therapeutics, 260, 355-363.
15. Kenna, G. A., Nielsen, D. M., Mello, P., Schiesl, A., & Swift, R. M. (2007). Pharmacotherapy of dual substance abuse and dependence. CNS Drugs, 21, 213-237.
16. Kleber, H. D. (2007). Pharmacologic treatments for opioid dependence: Detoxification and maintenance options. Dialogues in Clinical Neuroscience, 9, 455-470.
17. Kosten, T. R. (1991). Client issues in drug abuse treatment: Addressing multiple drug abuse. NIDA Research Monograph, 106, 136-151.
18. Kreek, M. J. (1988). Opiate-ethanol interactions: Implications for the biological basis and treatment of combined addictive diseases. NIDA Research Monograph, 81, 428-439.
19. Mannelli, P., Gottheil, E., Peoples, J. F., Oropeza, V. C., & Van Bockstaele, E. J. (2004). Chronic very low dose naltrexone administration attenuates opioid withdrawal expression. Biological Psychiatry, 56, 261-268.
20. Mannelli, P., & Pae, C. U. (2007). Medical comorbidity and alcohol dependence. Current Psychiatry Reports, 9, 217-224.
21. Mannelli, P., Patkar, A. A., Peindl, K., Gorelick, D. A., Wu, L. T., & Gottheil, E. (2009). Very low dose naltrexone addition in opioid detoxification: A randomized, controlled trial. Addiction Biology, 14, 204-213.
22. Maremmani, I., Pani, P. P., Mellini, A., Pacini, M., Marini, G., Lovrecic, M., Shinderman, M. (2007). Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program. Journal of Addictive Diseases, 26, 61-70.
23. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Argeriou, M. (1992). The fifth edition of the addiction severity index. Journal of Substance Abuse Treatment, 9, 199-213.
24. National Institute on Alcohol Abuse and Alcoholism. (2004). NIAAA council approves definition of binge drinking. NIAAA newsletter (NIH Publication No. 04-5346). Bethesda, MD.
25. Nava, F., Manzato, E., Leonardi, C., & Lucchini, A. (2008). Opioid maintenance therapy suppresses alcohol intake in heroin addicts with alcohol dependence: Preliminary results of an open randomized study. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 32, 1867-1872.
26. Nyamathi, A., Compton, P., Cohen, A., Marfi see, M., Shoptaw, S., Greengold, B., Leake, B. (2009). Correlates of hospitalization for alcoholusing methadone-maintained persons with physical health problems. Western Journal of Nursing Research, 31, 525-543.
27. O'Malley, S. S., Krishnan-Sarin, S., Farren, C., & O'Connor, P. G. (2000). Naltrexone-induced nausea in patients treated for alcohol dependence: Clinical predictors and evidence for opioid-mediated effects. Journal of Clinical Psychopharmacology, 20, 69-76.
28. Oncken, C., Van Kirk, J., & Kranzler, H. R. (2001). Adverse effects of oral naltrexone: Analysis of data from two clinical trials. Psychopharmacology, 154, 397-402.
29. Rice, C. (2007). Retest reliability of self-reported daily drinking: Form 90. Journal of Studies on Alcohol and Drugs, 68, 615-618.
30. Sabino, V., Cottone, P., Koob, G. F., Steardo, L., Lee, M. J., Rice, K. C., & Zorrilla, E. P. (2006). Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology, 189, 175-186.
31. Schuckit, M. A. (2009). Alcohol-use disorders. Lancet, 373, 492-501.
32. Schürks, M., Overlack, M., & Bonnet, U. (2005). Naltrexone treatment of combined alcohol and opioid dependence: Deterioration of co-morbid major depression. Pharmacopsychiatry, 38, 100-102.
33. Senbanjo, R., Wolff, K., & Marshall, J. (2007). Excessive alcohol consumption is associated with reduced quality of life among methadone patients. Addiction, 102, 257-263.
34. Sobell, L. C., Brown, J., Leo, G. I., & Sobell, M. B. (1996). The reliability of the Alcohol Timeline Followback when administered by telephone and by computer. Drug and Alcohol Dependence, 42, 49-54.
35. Srivastava, A., Kahan, M., & Ross, S. (2008). The effect of methadone maintenance treatment on alcohol consumption: A systematic review. Journal of Substance Abuse Treatment, 34, 215-223.
36. Stenbacka, M., Beck, O., Leifman, A., Romelsjö, A., & Helander, A. (2007). Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. Drug and Alcohol Review, 26, 55-63.
37. Stimmel, B., Korts, D., Cohen, M., Jackson, G., Sturiano, V., & Hanbury, R. (1981). Opiate addiction and alcoholism: The feasibility of combined treatment approaches. Annals of the New York Academy of Sciences, 362, 50-56.
38. Substance Abuse and Mental Health Services Administration (Offi ce of Applied Studies). (2006). Drug abuse warning network report. Rockville, MD: Author. [AU: Please verify this reference and provide the suggested citation or a link to the original document.] p. 3.
39. Substance Abuse and Mental Health Services Administration (Office of Applied Studies). (2009a). Results from the 2008 National Survey on Drug Use and Health: National findings (Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434). Rockville, MD.
40. Substance Abuse and Mental Health Services Administration (Office of Applied Studies). (2009b). The TEDS report: Heroin and other opiate admissions to substance abuse treatment. Rockville, MD.
41. Tucker, J. A., Foushee, H. R., Black, B. C., & Roth, D. L. (2007). Agreement between prospective interactive voice response self-monitoring and structured retrospective reports of drinking and contextual variables during natural resolution attempts. Journal of Studies on Alcohol and Drugs, 68, 538-542.
42. West, R., & Gossop, M. (1994). Overview: A comparison of withdrawal symptoms from different drug classes. Addiction, 89, 1483-1489